Search research articles
Contact Us
Filters
Showing results (61-70 of 148) with videos related to
Page
of 15
Sort By:
Molecular Cancer Therapeutics
|
January 25, 2006
The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization
Danhua Xiao, Atsuko Deguchi, Gregg G Gundersen, et al.
Pathologie-Biologie
|
October 1, 1976
[Kinetic study of human lymphocytes transformation in culture by lectin from Pisum sativum (author's transl)]
I Bernard-Griffiths, G Betail, D Godeneche, et al.
The Journal of Biological Chemistry
|
January 21, 2001
The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities
I Bernard-Pierrot, J Delbe, D Caruelle, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)
|
February 1, 1993
[Metastases in the cauda equina in visceral cancers. Apropos of 2 cases]
I Bernard, T Favier, P Menei, et al.
Molecular Carcinogenesis
|
January 1, 2008
Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G
Jae-Won Soh, Julhash U Kazi, Han Li, et al.
Biochemical and Biophysical Research Communications
|
December 22, 1999
Glycosaminoglycans promote HARP/PTN dimerization
I Bernard-Pierrot, M Héroult, G Lemaître, et al.
Cancer Research
|
May 19, 2007
Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells
Lin Wang, Yujing Zhang, Haiyang Li, et al.
Molecular Cancer Therapeutics
|
December 21, 2002
Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G
Atsuko Deguchi, Jae-Won Soh, Han Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Jin T E Lim, et al.
Journal of Experimental Therapeutics & Oncology
|
January 19, 2006
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Andrew K Joe, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 148) with videos related to
Sort By:
Page
of 15
Molecular Cancer Therapeutics
|
January 25, 2006
The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization
Danhua Xiao, Atsuko Deguchi, Gregg G Gundersen, et al.
Pathologie-Biologie
|
October 1, 1976
[Kinetic study of human lymphocytes transformation in culture by lectin from Pisum sativum (author's transl)]
I Bernard-Griffiths, G Betail, D Godeneche, et al.
The Journal of Biological Chemistry
|
January 21, 2001
The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities
I Bernard-Pierrot, J Delbe, D Caruelle, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)
|
February 1, 1993
[Metastases in the cauda equina in visceral cancers. Apropos of 2 cases]
I Bernard, T Favier, P Menei, et al.
Molecular Carcinogenesis
|
January 1, 2008
Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G
Jae-Won Soh, Julhash U Kazi, Han Li, et al.
Biochemical and Biophysical Research Communications
|
December 22, 1999
Glycosaminoglycans promote HARP/PTN dimerization
I Bernard-Pierrot, M Héroult, G Lemaître, et al.
Cancer Research
|
May 19, 2007
Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells
Lin Wang, Yujing Zhang, Haiyang Li, et al.
Molecular Cancer Therapeutics
|
December 21, 2002
Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G
Atsuko Deguchi, Jae-Won Soh, Han Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Jin T E Lim, et al.
Journal of Experimental Therapeutics & Oncology
|
January 19, 2006
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Andrew K Joe, et al.
Page
of 15